{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:43:19Z","timestamp":1763059399093,"version":"3.44.0"},"reference-count":77,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["2020111061"],"award-info":[{"award-number":["2020111061"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027026","name":"Johnson and Johnson Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Therapeutic goals in inflammatory bowel disease (IBD) are constantly evolving due to novel medical options and diagnostic tools, yet unmet clinical needs persist.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>We aimed to establish a consensus definition for partial responders in clinical practice, considered as patients failing to meet defined objectives within the desired time frame.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>A two-round Delphi consultation was held with IBD-specialized gastroenterologists.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The 22-item questionnaire covered four clinical scenarios: (1) moderate ulcerative colitis (UC); (2) acute severe UC; (3) luminal Crohn\u2019s disease (CD); and (4) perianal CD. Consensus was defined when \u2a7e70% of panellists agreed with a statement, rated using a 7-point Likert scale. We also analysed the associated annual costs for partial responders and patients in remission according to the agreed long-term definitions, based on a literature review and the experience of the scientific committee. Medication costs were excluded from the analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Sixty Spanish gastroenterologists with extensive experience in IBD management participated in the consultation. Consensus was achieved on partial response definitions with different criteria over time, including clinical scores, biomarkers and imaging or endoscopic examinations. The annual cost for partial responders and patients in remission was estimated at \u20ac2570.40 and \u20ac820.20 for UC, \u20ac1607.30 and \u20ac718.0 for luminal CD and \u20ac2886.70 and \u20ac888.80 for perianal CD, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The concept of partial responders has been defined in four clinical scenarios. Patients achieving prolonged remission could provide 55%\u201370% savings in non-pharmacological resource use and associated costs. Our study could help healthcare professionals in decision-making, ultimately improving patient care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1177\/17562848251360907","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T12:02:51Z","timestamp":1755518571000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1133-4578","authenticated-orcid":false,"given":"Iago","family":"Rodr\u00edguez-Lago","sequence":"first","affiliation":[{"name":"Hospital de Galdakao-Usansolo, Galdakao, Spain"},{"name":"Biobizkaia Health Research Institute, Galdakao, Spain"},{"name":"Department of Medicine, Faculty of Health Sciences, University of Deusto, Galdakao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-3726","authenticated-orcid":false,"given":"Luis","family":"Mench\u00e9n","sequence":"additional","affiliation":[{"name":"Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Departamento de Medicina, Universidad Complutense, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Germ\u00e1n","family":"S\u00e1nchez-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Complejo Asistencial Universitario de Salamanca, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Guardiola","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge, L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Merino-Boh\u00f3rquez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen Macarena, Seville, Spain"},{"name":"Departamento de Farmacolog\u00eda, Facultad de Farmacia, Universidad de Sevilla, Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Garcill\u00e1n","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Moreno-Cubero","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Vispo","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeni","family":"Dom\u00e8nech","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona and CIBEREHD, Carretera del Canyet s\/n 08916, Badalona, Catalonia 08916, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/phrs.2021.1603990"},{"key":"e_1_3_4_3_2","unstructured":"Manejo de la Enfermedad Inflamatoria Intestinal. Revisi\u00f3n y algoritmos de tratamiento [Internet]. Revista ACTA https:\/\/actagastro.org\/manejo-de-la-enfermedad-inflamatoria-intestinal-revision-y-algoritmos-de-tratamientos\/ (2019 accessed 29 November 2022)."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.20805.1"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v3.i6.479"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/68986"},{"issue":"1","key":"e_1_3_4_7_2","first-page":"92","article-title":"Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease","volume":"20","author":"Iglesias-Rey M","year":"2014","unstructured":"Iglesias-Rey M, Barreiro-de Acosta M, Caama\u00f1o-Isorna F, et al. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis 2014; 20(1): 92\u2013102.","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.005"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0700-2"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2024.502203"},{"issue":"1","key":"e_1_3_4_11_2","first-page":"53","article-title":"Enfermedad inflamatoria intestinal","author":"Mart\u00edn de Carpi J","year":"2021","unstructured":"Mart\u00edn de Carpi J. Enfermedad inflamatoria intestinal. Adolescere 2021; IX(1): 53\u201361.","journal-title":"Adolescere"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02473-6"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132885"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.233"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/gastroent12020020"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i35.6385"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21792"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad159"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0211-1"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12288"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2024.2326838"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12714"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-013-0315-7"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx174"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy238"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-023-08220-9"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.003"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.09.046"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103418"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3212"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00279"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110901"},{"key":"e_1_3_4_34_2","first-page":"10","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu C-C","year":"2007","unstructured":"Hsu C-C, Sandford BA. The Delphi technique: making sense of consensus. Pract Assess Res Eval 2007; 12: 10.","journal-title":"Pract Assess Res Eval"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216317690685"},{"key":"e_1_3_4_36_2","unstructured":"Gisbert R Brosa M. Base de datos de costes sanitarios y ratios coste-efectividad espa\u00f1oles: eSalud [Internet]. Barcelona: Oblikue Consulting S.L. http:\/\/www.oblikue.com\/bddcostes\/ (2007 June 2024)."},{"key":"e_1_3_4_37_2","unstructured":"Government of Spain (Gobierno de Espa\u00f1a) Ministry of the Presidency (Ministerio de la Presidencia) and State Agency Official Bulletin of the State (Agencia Estatal Bolet\u00edn Oficial del Estado). Organic Law 3\/2018 of December 5 on the Protection of Personal Data and Guarantee of Digital Rights (Ley Org\u00e1nica 3\/2018 de 5 de diciembre de Protecci\u00f3n de Datos Personales y garant\u00eda de los derechos digitales) http:\/\/www.boe.es\/buscar\/doc.php?id=BOE-A-2018-16673 (2018 accessed June 2024)."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab026"},{"key":"e_1_3_4_39_2","unstructured":"D\u2019Haens G. Induction and maintenance of remission in IBD: where are we coming from; where could we go? [Internet]. Europa.eu https:\/\/www.ema.europa.eu\/en\/documents\/presentation\/presentation-induction-maintenance-remission-ibd-where-are-we-coming-where-could-we-go-geert-dhaens_en.pdf (accessed 1 December 2022)."},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.09.076"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i22.2902"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2021.06.005"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000492322"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.12485"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2016.4447\/2016"},{"issue":"6","key":"e_1_3_4_46_2","article-title":"Biologic therapy in inflammatory bowel disease","volume":"60","author":"Theede K","year":"2013","unstructured":"Theede K, Dahlerup JF, Fallingborg J, et al. Biologic therapy in inflammatory bowel disease. Dan Med J 2013; 60(6): B4652.","journal-title":"Dan Med J"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-200910003-01183"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.22516\/25007440.52"},{"issue":"3","key":"e_1_3_4_49_2","first-page":"2022","article-title":"Real-world effectiveness of vedolizumab dose escalation in patients with inflammatory bowel disease: a systematic literature review","volume":"360","author":"Patel D","unstructured":"Patel D, Martin S, Luo M, et al. Real-world effectiveness of vedolizumab dose escalation in patients with inflammatory bowel disease: a systematic literature review. Crohns Colitis 360 2022; 4(3): otac020.","journal-title":"Crohns Colitis"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271299"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i9.1142"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03732.x"},{"key":"e_1_3_4_53_2","article-title":"P246 Persistent burden of disease in patients with Crohn\u2019s disease treated with biologic therapy: results from a real-world survey in the United States (US), France, Germany, Italy, Spain, and United Kingdom (5EU)","volume":"16","author":"Sikirica M","year":"2022","unstructured":"Sikirica M, Lynch J, Kershaw J, et al. P246 Persistent burden of disease in patients with Crohn\u2019s disease treated with biologic therapy: results from a real-world survey in the United States (US), France, Germany, Italy, Spain, and United Kingdom (5EU). J Crohns Colitis 2022; 16: i292\u2013i293.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.06.068"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16892"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1880892"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18137159"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2019.1604219"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad037"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.05.015"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2022.10.017"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105075"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v5.i4.579"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.3393\/ac.2021.02.08"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000608"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.33590\/emjgastroenterol\/10311269"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2016.02.008"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58040486"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281f395"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30206-0"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab029"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303376"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-02028-5"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1627579"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.05.052"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.12.004"},{"issue":"10","key":"e_1_3_4_77_2","first-page":"2254","article-title":"Silent Crohn\u2019s disease: asymptomatic patients with elevated C-reactive protein are at risk for subsequent hospitalization","volume":"21","author":"Click B","year":"2015","unstructured":"Click B, Vargas EJ, Anderson AM, et al. Silent Crohn\u2019s disease: asymptomatic patients with elevated C-reactive protein are at risk for subsequent hospitalization. Inflamm Bowel Dis 2015; 21(10): 2254\u20132261.","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002964"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848251360907","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562848251360907","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848251360907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T01:27:43Z","timestamp":1755739663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562848251360907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":77,"alternative-id":["10.1177\/17562848251360907"],"URL":"https:\/\/doi.org\/10.1177\/17562848251360907","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"type":"print","value":"1756-2848"},{"type":"electronic","value":"1756-2848"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"17562848251360907"}}